B12 Deficiency in Women: Symptoms, Causes, and When to See a Doctor

Why Women Are at Particular Risk for B12 Deficiency

Women face B12 deficiency at disproportionately higher rates than men, and the reasons are largely sex-specific. The autoimmune condition most responsible for severe B12 depletion, pernicious anemia, affects women two to three times more often than men. Hormonal shifts across the menstrual cycle, pregnancy, and menopause each create conditions that increase demand for or reduce absorption of B12.

B12 is absorbed in the terminal ileum through a two-step process: first, stomach acid separates it from food protein, then intrinsic factor (a protein made by gastric parietal cells) carries it across the gut wall. Anything that disrupts stomach acid or intrinsic factor production breaks this chain. Women are more likely than men to use proton pump inhibitors (PPIs), to develop autoimmune gastritis, and to follow plant-based diets, all of which directly impair B12 absorption.

The Autoimmune Connection

Pernicious anemia occurs when the immune system destroys the gastric parietal cells that produce intrinsic factor. Studies estimate it affects approximately 0.1% of the general population but up to 1.9% of women over 60. Women with other autoimmune conditions, including Hashimoto's thyroiditis, type 1 diabetes, and rheumatoid arthritis, carry a meaningfully higher risk of developing pernicious anemia.

Metformin and PCOS

If you have PCOS and take metformin, your B12 status deserves regular monitoring. A 2010 meta-analysis published in the Archives of Internal Medicine found that metformin reduces B12 levels in approximately 29% of long-term users, likely by interfering with calcium-dependent intrinsic factor absorption in the ileum. PCOS is the most common endocrine disorder in reproductive-age women, affecting 8-13% of this population globally, and metformin remains a first-line treatment for many. This intersection makes routine B12 monitoring in metformin-treated PCOS essential, not optional.

Symptoms of B12 Deficiency in Women (by Life Stage)

The symptoms of B12 deficiency are wide-ranging and frequently overlap with other common women's health conditions. This overlap is exactly why deficiency goes undiagnosed for months or years.

Reproductive Years (Ages 18-44)

During the reproductive years, B12 deficiency most often presents as:

• Unexplained fatigue that does not improve with rest
• Brain fog and difficulty concentrating
• Mood changes, including low mood or increased anxiety
• Irregular or heavy periods (indirectly, through associated anemia)
• Tingling or numbness in hands and feet
• Sore, inflamed tongue (glossitis)
• Pale or slightly yellow skin

These symptoms are easily attributed to iron-deficiency anemia, depression, or burnout. A review in the American Journal of Clinical Nutrition noted that functional B12 deficiency can exist even when serum levels appear borderline normal, which is why testing methylmalonic acid (MMA) and homocysteine alongside serum B12 gives a more accurate picture.

Trying to Conceive and Pregnancy

B12 deficiency in the periconception window is a serious concern. Low maternal B12 is independently associated with increased risk of neural tube defects, recurrent miscarriage, and preterm birth. The developing neural tube closes by day 28 of pregnancy, often before a woman knows she is pregnant. Adequate B12 stores before conception matter enormously.

During pregnancy, symptoms of deficiency can be mistaken for normal pregnancy changes: fatigue, nausea, and mood shifts are expected in the first trimester. This masking effect makes pre-pregnancy testing especially valuable.

Postpartum and Lactation

Breastfed infants depend entirely on their mother's milk for B12. Breast milk B12 concentration directly reflects maternal B12 status, and infants of deficient mothers are at risk for megaloblastic anemia and developmental regression, including loss of milestones already achieved. Postpartum depletion is real. If you followed a plant-based diet during pregnancy or had hyperemesis gravidarum limiting your diet, postpartum B12 testing is a reasonable step.

Perimenopause

Perimenopause, typically starting in the mid-to-late 40s, brings a cluster of symptoms that overlap nearly perfectly with B12 deficiency: fatigue, brain fog, mood instability, sleep disruption, and tingling sensations. Estrogen decline during perimenopause appears to influence gastric acid secretion, which can modestly reduce B12 absorption from food. A perimenopausal woman presenting with cognitive symptoms or mood changes should have B12 checked before attributing everything to estrogen.

Postmenopause

Postmenopausal women carry the highest population risk. Atrophic gastritis, a condition where the stomach lining thins and produces less acid, becomes increasingly common after 60. Prevalence of atrophic gastritis in adults over 60 reaches 20-30% in some population studies. Add PPI use, which is extremely common in this age group, and you have a population where subclinical B12 deficiency is likely under-diagnosed at scale.

What Causes B12 Deficiency in Women: The Main Drivers

Dietary Insufficiency

B12 exists almost exclusively in animal-sourced foods: meat, fish, dairy, and eggs. Strict vegans who do not supplement are virtually guaranteed to become deficient over time. The NIH Office of Dietary Supplements sets the Recommended Dietary Allowance for adult women at 2.4 mcg/day, rising to 2.6 mcg/day in pregnancy and 2.8 mcg/day during lactation. Plant-based milks and nutritional yeast are sometimes fortified, but relying on them without confirmed B12 content and quantity is unreliable.

Absorption Problems

Even women eating adequate B12 can become deficient if absorption is impaired. Key causes include:

• Pernicious anemia. Autoimmune destruction of intrinsic factor-producing cells. Oral supplementation at standard doses does not fix this; high-dose oral B12 (1,000 mcg or more daily) works through passive diffusion, or intramuscular injections bypass the gut entirely.
• Proton pump inhibitor (PPI) use. Long-term PPI use for two or more years is associated with a significantly increased risk of B12 deficiency. A 2013 study in JAMA found a dose-response relationship: the higher the PPI dose and the longer the duration, the greater the deficiency risk.
• Metformin. As described above, approximately 30% of long-term users develop lower B12 levels.
• H. Pylori infection. This bacteria damages parietal cells and reduces intrinsic factor production. H. Pylori affects roughly 44% of the global population and is more prevalent in women in certain demographic groups.
• Gastrointestinal surgery. Gastric bypass surgery, increasingly common among women seeking treatment for obesity, removes or bypasses much of the stomach, dramatically reducing intrinsic factor production. Post-bariatric B12 deficiency is reported in 30-40% of patients without supplementation.
• Crohn's disease and celiac disease. Both damage the terminal ileum where B12 is absorbed.

Medications Beyond Metformin

Several medications commonly prescribed to women reduce B12 levels or absorption:

• Histamine-2 receptor antagonists (famotidine, ranitidine)
• Long-term use of colchicine for recurrent pericarditis or other conditions
• High-dose vitamin C supplementation (may destroy B12 in the gut)

How B12 Deficiency Is Diagnosed

The Standard Blood Test

A serum B12 level is the first-line test. Most laboratories flag levels below 200 pg/mL as deficient. The borderline range of 200-300 pg/mL is clinically significant and should not be dismissed, particularly if you have symptoms.

Functional Markers: MMA and Homocysteine

Serum B12 alone misses a meaningful proportion of functional deficiencies. Elevated methylmalonic acid (MMA) and elevated homocysteine are more sensitive indicators of tissue-level B12 deficiency, because they reflect what is actually happening inside cells. If your serum B12 is borderline and you have symptoms, ask for these two markers.

• MMA rises specifically with B12 deficiency (not folate deficiency)
• Homocysteine rises with both B12 and folate deficiency

Complete Blood Count Findings

Megaloblastic anemia, the classic hematological picture of B12 deficiency, shows:

• Elevated mean corpuscular volume (MCV), meaning larger-than-normal red blood cells
• Hypersegmented neutrophils on peripheral smear
• Low hemoglobin in more advanced cases

Neurological damage from B12 deficiency can occur without anemia. Up to 28% of patients with neurological manifestations of B12 deficiency have no anemia at presentation. Do not let a normal CBC give you false reassurance if neurological symptoms are present.

Testing for Underlying Cause

Once deficiency is confirmed, identifying the cause directs treatment. Your clinician may order:

• Anti-intrinsic factor antibodies and anti-parietal cell antibodies (for pernicious anemia)
• H. Pylori testing
• Review of current medications
• Celiac serology if gastrointestinal symptoms co-exist

When to Worry: Red-Flag Symptoms That Need Prompt Attention

Most B12 deficiency develops slowly. But certain presentations call for faster action.

See a clinician within days, not weeks, if you notice:

• Progressive numbness or weakness in your legs or arms
• Difficulty walking or balance problems
• Memory loss or confusion that is new and worsening
• Vision changes
• Mouth ulcers that are not healing combined with a pale complexion and extreme fatigue

Subacute combined degeneration of the spinal cord is a neurological complication of severe B12 deficiency that causes demyelination of the dorsal and lateral columns. It can become irreversible if deficiency is not corrected within weeks to a few months of symptom onset. Speed of treatment matters.

Do not wait for a scheduled annual exam if neurological symptoms are present.

B12 Deficiency in Pregnancy and Lactation

Pregnancy category: B12 is a water-soluble vitamin, not a teratogen. Deficiency, however, is the danger. Maternal B12 deficiency is associated with neural tube defects, intrauterine growth restriction, and increased miscarriage risk. The fetus is a preferential consumer of maternal B12, meaning your stores deplete faster during pregnancy.

ACOG recommends that all prenatal vitamins contain at least 2.6 mcg of B12, but women at risk of deficiency (vegans, those with prior gastric surgery, metformin users, or those with autoimmune conditions) need confirmed adequacy of B12 status, not just a prenatal vitamin.

Lactation: B12 transfers into breast milk. Studies show breast milk from B12-replete mothers contains approximately 0.4-0.5 mcg per 100 mL, which is sufficient for an exclusively breastfed infant. If you are deficient, your milk will be deficient. Infants who develop B12 deficiency through low-B12 breast milk can experience severe developmental regression, including loss of head control and purposeful movement, within months.

For vegan or vegetarian mothers: Supplementation during pregnancy and lactation is not optional. The NIH recommends 2.8 mcg/day during breastfeeding, but most clinicians treating vegan mothers use supplementation doses substantially higher than this to ensure adequate milk transfer.

Contraception note: B12 is not a teratogen and does not require contraception, but women of reproductive age who are found to be deficient should correct their B12 before planning a pregnancy, given the neural tube defect risk in early gestation.

Treatment for B12 Deficiency in Women

Oral Supplementation

For women whose deficiency stems from inadequate dietary intake and who have normal absorption, oral cyanocobalamin or methylcobalamin at 1,000-2,000 mcg daily effectively restores B12 levels, even though the RDA is only 2.4 mcg. The high oral dose works through passive diffusion across the gut lining, which does not require intrinsic factor. This means oral high-dose supplementation can also work in pernicious anemia, though many clinicians still prefer injections for confirmed pernicious anemia to ensure certainty of absorption.

Intramuscular Injections

Hydroxocobalamin or cyanocobalamin injections are given intramuscularly, typically 1,000 mcg. For active neurological symptoms, the standard regimen in UK NICE guidelines is 1,000 mcg hydroxocobalamin injected on alternate days until no further neurological improvement, then every two months long-term. For non-neurological deficiency, loading doses of six injections over two weeks are followed by maintenance every three months.

Dietary Sources and Fortified Foods

For women managing mild insufficiency through diet:

• Beef liver: 70.7 mcg per 3-oz serving (one of the most concentrated sources)
• Clams: 84.1 mcg per 3-oz serving
• Salmon: 4.9 mcg per 3-oz serving
• Low-fat milk: 1.2 mcg per cup
• Nutritional yeast (fortified): varies by brand, check label

Monitoring Response

Retesting serum B12, MMA, and a complete blood count at 8-12 weeks after starting treatment confirms response. Neurological symptoms may take longer to improve than hematological findings. Some nerve symptoms improve over months.

Who This Matters Most For: A Life-Stage Guide

Understanding your personal risk profile helps you advocate for appropriate testing.

Reproductive-age women (18-44):

• Vegan or vegetarian diet without confirmed supplementation
• Long-term metformin use for PCOS or insulin resistance
• History of recurrent miscarriage or neural tube defect in a prior pregnancy
• Any autoimmune condition (Hashimoto's, type 1 diabetes, IBD)

Trying to conceive:

• Test B12 before stopping contraception if any of the above risk factors apply
• Correct deficiency before conception, not after a positive pregnancy test

Pregnant and postpartum:

• Prenatal vitamin B12 content matters; check the label
• Breastfeeding vegans must supplement reliably; maternal dietary intent alone does not protect the infant

Perimenopausal women (typically 45-55):

• New fatigue, brain fog, and mood symptoms warrant B12 testing alongside FSH and thyroid
• Do not accept "it's just perimenopause" without at least ruling out B12 deficiency

Postmenopausal women (55+):

• PPI use, atrophic gastritis, and age-related decline in gastric acid make this the highest-risk group
• Annual B12 monitoring is reasonable if you are on long-term PPIs or metformin

The Evidence Gap: What We Do Not Know Yet

Women have been under-represented in the trials that established B12 dosing thresholds and treatment protocols. Most foundational absorption studies were conducted in predominantly male or mixed populations without sex-stratified analysis. The optimal serum B12 threshold for women at different hormonal life stages is genuinely unknown. Whether estrogen levels influence the functional adequacy of a given serum B12 concentration has not been studied directly.

As WomanRx reviewer Elena Vasquez, MD, puts it: "We have a serum cutoff of 200 pg/mL that was set without asking whether that number means the same thing in a 28-year-old with PCOS, a 50-year-old in perimenopause, or a 70-year-old with atrophic gastritis. The honest answer is we do not know. That is why I test functional markers, not just serum B12, in any symptomatic woman."

This is not a reason to avoid testing. It is a reason to test more completely: serum B12 plus MMA plus homocysteine, paired with your full clinical picture.